It is often referred to in literature as a “Fedratinib intermediate” or “Fedratinib Impurity 1” when used as a reference standard. 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is a key intermediate employed to synthesize Fedratinib, an FDA-approved kinase inhibitor for the treatment of myelofibrosis.
4-(2-(Pyrrolidin-1-yl)ethoxy)aniline
| API Name | Fedratinib |
|---|---|
| CAS No | 50609-01-3 |
| Molecular Formula | C12H18N2O |
| Molecular Weight | 206.28 g/mol |
| Synonyms | 4-(2-pyrrolidin-1-ylethoxy)aniline |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is often referred to in literature as a "Fedratinib intermediate" or "Fedratinib Impurity 1" when used as a reference standard. 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is a key intermediate employed to synthesize Fedratinib, an FDA-approved kinase inhibitor for the treatment of myelofibrosis.
The CAS number of 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is 50609-01-3.
The molecular formula of 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is C12H18N2O.
The listed molecular weight of 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is 206.28 g/mol.
4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is listed as being used in connection with the following API: Fedratinib.
The listed synonym or IUPAC name for 4-(2-(Pyrrolidin-1-yl)ethoxy)aniline is 4-(2-pyrrolidin-1-ylethoxy)aniline.